Amgen, Inc. (AMGN)
443.80
-14.14
(-3.09%)
USD |
NASDAQ |
Nov 18, 16:00
444.87
+1.08
(+0.24%)
After-Hours: 19:42
Amgen Total Return Level : 685.72 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 685.72 |
| November 16, 2026 | 692.29 |
| November 13, 2026 | 697.31 |
| November 12, 2026 | 699.39 |
| November 11, 2026 | 700.96 |
| November 10, 2026 | 696.65 |
| November 09, 2026 | 696.65 |
| November 06, 2026 | 689.45 |
| November 05, 2026 | 689.24 |
| November 04, 2026 | 716.49 |
| November 03, 2026 | 690.70 |
| November 02, 2026 | 696.98 |
| October 30, 2026 | 697.82 |
| October 29, 2026 | 689.91 |
| October 28, 2026 | 676.58 |
| October 27, 2026 | 670.77 |
| October 26, 2026 | 665.80 |
| October 23, 2026 | 657.76 |
| October 22, 2026 | 669.77 |
| October 21, 2026 | 656.38 |
| October 20, 2026 | 657.28 |
| October 19, 2026 | 636.32 |
| October 16, 2026 | 647.62 |
| October 15, 2026 | 649.93 |
| October 14, 2026 | 638.07 |
| Date | Value |
|---|---|
| October 13, 2026 | 618.20 |
| October 12, 2026 | 625.28 |
| October 09, 2026 | 621.24 |
| October 08, 2026 | 610.11 |
| October 07, 2026 | 618.56 |
| October 06, 2026 | 602.87 |
| October 05, 2026 | 603.43 |
| October 02, 2026 | 603.52 |
| October 01, 2026 | 609.86 |
| September 30, 2026 | 631.18 |
| September 29, 2026 | 634.37 |
| September 28, 2026 | 626.12 |
| September 25, 2026 | 620.85 |
| September 24, 2026 | 608.02 |
| September 23, 2026 | 608.09 |
| September 22, 2026 | 614.31 |
| September 21, 2026 | 588.73 |
| September 18, 2026 | 577.48 |
| September 17, 2026 | 568.69 |
| September 16, 2026 | 563.56 |
| September 15, 2026 | 562.51 |
| September 14, 2026 | 571.27 |
| September 11, 2026 | 565.06 |
| September 10, 2026 | 572.72 |
| September 09, 2026 | 585.90 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Gilead Sciences, Inc. | 249.53 |
| Regeneron Pharmaceuticals, Inc. | 966.64 |
| AbbVie, Inc. | 507.46 |
| Biogen, Inc. | 250.79 |
| Vertex Pharmaceuticals, Inc. | 534.20 |